Trial
NCT01729884
Vaccine Therapy in Treating Patients With Stage IV Hormone Receptor Positive Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
National Cancer Institute (NCI)
Condition
HER2-positive Breast Cancer
Intervention
HER-2/neu peptide vaccine
Why stopped
Study ended early due to slow enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-11